Key questions include:

• How are teams successfully translating high-throughput, discovery-stage LNP workflows into robust, GMP-ready processes without compromising product quality?
• Where do current LNP workflows break when moving from preclinical into clinical and commercial scale – and how can these gaps be addressed early?
• What needs to change today to ensure LNP platforms remain scalable, reproducible, and cost-effective as products move toward global commercial supply?